The Impact of Mass Drug Administration on Lymphatic Filariasis

The Impact of Mass Drug Administration on Lymphatic Filariasis

Mass drug administration (MDA) has made a significant impact on the control of lymphatic filariasis (LF) since the establishment of the Global Programme to Eliminate Lymphatic Filariasis. However, its implementation is associated with several challenges, hampering interruption of parasite transmissi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Isaac Frimpong Aboagye, Yvonne Abena Afadua Addison
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Journal of Tropical Medicine
Online Access:	http://dx.doi.org/10.1155/2022/7504871
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of mass drug administration for elimination of lymphatic filariasis in Nepal.
by: Chet Raj Ojha, et al.
Published: (2017-07-01)

Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis.
by: Wilma A Stolk, et al.
Published: (2013-01-01)

Cessation of mass drug administration for lymphatic filariasis in Zanzibar in 2006: was transmission interrupted?
by: Maria P Rebollo, et al.
Published: (2015-03-01)

Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea.
by: Daniel J Tisch, et al.
Published: (2011-07-01)

Cost-effectiveness of vector control for supplementing mass drug administration for eliminating lymphatic filariasis in India.
by: Donald S Shepard, et al.
Published: (2024-12-01)

Clinical profile and Mass Drug Administration coverage in patients with lymphatic filariasis: A descriptive study
by: Sumit Pareek, et al.
Published: (2025-07-01)

Microplanning improves stakeholders' perceived capacity and engagement to implement lymphatic filariasis mass drug administration.
by: Caitlin M Worrell, et al.
Published: (2025-03-01)

Evaluating the effectiveness of mass drug administration on lymphatic filariasis transmission and assessment of post-mass drug administration surveillance in Nigeria’s Federal Capital Territory
by: Juliana Ajuma Amanyi-Enegela, et al.
Published: (2025-07-01)

Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.
by: Subramanian Swaminathan, et al.
Published: (2012-01-01)

Acceptability of mass drug administration for lymphatic filariasis in Baglung Municipality of Nepal: A mixed-method study
by: Muskan Pudasainee, et al.
Published: (2025-01-01)

Acceptability of mass drug administration for lymphatic filariasis in Baglung Municipality of Nepal: A mixed-method study.
by: Muskan Pudasainee, et al.
Published: (2025-01-01)

Mass drug administration to eliminate lymphatic filariasis: A population-based coverage and compliance study in Eastern India
by: Shubhashisha Mohanty, et al.
Published: (2024-11-01)

Factors influencing participation of elderly population in mass drug administration for lymphatic filariasis: a cross-sectional study
by: Muhammed Jabir, et al.
Published: (2024-11-01)

Impact of mass drug administration with ivermectin, diethylcarbamazine, and albendazole for lymphatic filariasis on hookworm and Strongyloides stercoralis infections in Papua New Guinea.
by: Jannet A Tobon Ramos, et al.
Published: (2025-03-01)

Epidemiology of Lymphatic Filariasis Antigen and Microfilaria in Samoa, 2019: 7–9 Months Post Triple-Drug Mass Administration
by: Helen J. Mayfield, et al.
Published: (2024-12-01)

Epidemiological monitoring survey to assess the impact of mass drug administration with triple-drug regimen in lymphatic filariasis elimination programme in an endemic district in Southern India.
by: Kaliannagounder Krishnamoorthy, et al.
Published: (2025-08-01)

Coverage and evaluation survey of post-mass drug administration for lymphatic filariasis in four endemic districts of Uttar Pradesh: Are we on the track?
by: Sourabh Paul, et al.
Published: (2025-04-01)

Elimination of lymphatic filariasis in the Gambia.
by: Maria P Rebollo, et al.
Published: (2015-03-01)

Acceptance of Mass Drug Administration for Prophylaxis against Lymphatic Filariasis in a Tribal Endemic Area: A Descriptive Cross-sectional Study
by: Asmit Agarwal, et al.
Published: (2024-04-01)

Correction: Exploring factors affecting quality implementation of lymphatic filariasis mass drug administration in Bole and Central Gonja Districts in Northern Ghana.
by: Alfred Kwesi Manyeh, et al.
Published: (2021-04-01)

Outcome assessment of the implementation of Mass Drug Administration against lymphatic filariasis in Kalaburagi (Gulbarga) Karnataka, India: A cross-sectional survey
by: Puttamaligaiah Subhas Babu, et al.
Published: (2024-11-01)

Lymphatic Filariasis Disseminating to the Upper Extremity
by: Catherine Maldjian, et al.
Published: (2014-01-01)

Lymphatic Filariasis: Progress Towards Elimination
by: Ranganath BG
Published: (2016-06-01)

The Impact of Lymphatic Filariasis Mass Drug Administration Scaling Down on Soil-Transmitted Helminth Control in School-Age Children. Present Situation and Expected Impact from 2016 to 2020.
by: Denise Mupfasoni, et al.
Published: (2016-12-01)

Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016.
by: Meru Sheel, et al.
Published: (2018-07-01)

Costs of Transmission Assessment Surveys to Provide Evidence for the Elimination of Lymphatic Filariasis.
by: Molly A Brady, et al.
Published: (2017-02-01)

Mapping the geographical distribution of lymphatic filariasis in Zambia.
by: Enala T Mwase, et al.
Published: (2014-02-01)

Postelimination Cluster of Lymphatic Filariasis, Futuna, 2024
by: Clément Couteaux, et al.
Published: (2025-03-01)

Improving drug delivery strategies for lymphatic filariasis elimination in urban areas in Ghana.
by: Nana-Kwadwo Biritwum, et al.
Published: (2017-05-01)

The effects of variable spatial aggregation on lymphatic filariasis transmission
by: Callum Shaw, et al.
Published: (2025-01-01)

Evaluation of mass drug administration under the National Vector Borne Disease Control Program for lymphatic filariasis elimination in rural area of Telangana: A community-based cross-sectional study
by: Ratna Balaraju, et al.
Published: (2025-04-01)

Lymphatic Endothelial Cell in Endemic Bancroftian Filariasis: A Focus on the Lymphatics of the Tunica Vaginalis Testis
by: Jose Figueredo-Silva, et al.
Published: (2018-01-01)

Elimination of lymphatic filariasis as a public health problem in Malawi.
by: John Chiphwanya, et al.
Published: (2024-02-01)

Assessment of transmission in areas of uncertain endemicity for lymphatic filariasis in Brazil.
by: Amanda Xavier, et al.
Published: (2019-11-01)

Experience of Health System Personnel in the Implementation of Mass Distribution Campaigns for the Control of Lymphatic Filariasis in Rural Guinea in 2022
by: Akoi Zoumanigui, et al.
Published: (2024-11-01)

Application of the Filariasis CELISA Antifilarial IgG𝟒 Antibody Assay in Surveillance in Lymphatic Filariasis Elimination Programmes in the South Pacific
by: Hayley Joseph, et al.
Published: (2011-01-01)

Lymphatic filariasis as an indigenous illness: the local context of a global disease
by: Jonathan Roberts, et al.
Published: (2025-12-01)

Confirmatory mapping for lymphatic filariasis in districts previously considered nonendemic in Ghana
by: Joseph L. Opare, et al.
Published: (2025-03-01)

Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
by: Christina A Bulman, et al.
Published: (2015-02-01)

Global programme to eliminate lymphatic filariasis: the processes underlying programme success.
by: Kazuyo Ichimori, et al.
Published: (2014-12-01)